Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
Open accessThe DOI matches its Crossref record; 148 of the 150 references it cites were found in a registry or an index.
Abstract
Cancer stem cells are a subset of cells within the tumor that possess the ability to self-renew as well as differentiate into different cancer cell lineages. The exact mechanisms by which cancer stem cells arise is still not completely understood. However, current research suggests that cancer stem cells may originate from normal stem cells that have undergone genetic mutations or epigenetic changes. A more recent discovery is the dedifferentiation of cancer cells to stem-like cells. These stem-like cells have been found to express and even upregulate induced pluripotent stem cell markers known as Yamanaka factors. Here we discuss developments in how cancer stem cells arise and consider how environmental factors, such as hypoxia, plays a key role in promoting the progression of cancer stem cells and metastasis. Understanding the mechanisms that give rise to these cells could have important implications for the development of new strategies in cancer treatments and therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, hypoxia promotes self-renewal by activation of Wnt and Notch signaling pathways and embryonic stem cell transcription factors, and it modulates differentiation of tumor cells and tumor-associated stromal cells [86,87,88].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [87]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“Several markers have been reported to be expressed in CSCs including the Yamanaka transcription factors OCT4, NANOG, SOX2, KLF4, and c-MYC (62, 63).”
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“This was followed by the discovery of CSCs within a solid breast tumor environment (16).”
BackgroundBonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864 · cited 4×
“Two landmark studies involving immune-deficient mice models showed that leukemic cells expressing the same markers seen in adult human hematopoietic stem cells (CD34+CD38−) initiated hematopoietic malignancy (15, 38).”
BackgroundInfluentialCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162 · cited 1×
“Historically, cancer progression has been firmly established in mutational processes and clonal expansion (107).”
BackgroundEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067 · cited 1×
“However, recent studies have implicated CSCs in the resistance (108) and recurrence of tumors (109).”
BackgroundEpithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066 · cited 1×
“It is well known that hypoxia promotes tumor changes, such as EMT and dysfunctional vascularization, leading to cell migration and metastatic disease (114).”
BackgroundVascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906 · cited 3×
“Abnormal expression of NANOG, a differentiated HOX domain protein, has been reported in several human cancers including breast cancer (76), lung cancer (77), adenocarcinoma (78), and gastric cancer (79).”
BackgroundNew approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354 · cited 1×
“HIF-1a and HIF-2a were also shown to be required for VEGF expression in stem cells, but only HIF-1a expression was required for VEGF expression in non-stem populations (55).”
BackgroundMigrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352 · cited 1×
“In 2005, the “migratory cancer stem (MCS) cell” theory established the association between CSCs and EMT, which describes a ‘mobile CSC’ as a stationary CSC with partial EMT that disseminates and retains stem cell features, forming metastatic colonies (113).”
BackgroundMu, P., Zhang, Z., Benelli, M., Karthaus, W. R., Hoover, E., Chen, C.-C., Wongvipat, J., Ku, S.-Y., Gao, D., Cao, Z., et al. (2017) · Science · doi:10.1126/science.aah4307 · Cited by 1,050 · cited 1×
“Furthermore, elevated levels of SOX2 expression have also been associated with several cancers including breast (68), prostate (69), and pancreatic cancer (70).”
BackgroundCancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
Zhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971 · cited 1×
“NANOG then serves as a HIF-1 coactivator for the transcription of telomerase reverse transcriptase, an essential component for telomerase activity in telomere elongation (85, 86).”
BackgroundCancer stem cells as key drivers of tumour progression
Ayob, A. Z., & Ramasamy, T. S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0426-4 · Cited by 910 · cited 1×
“In contrast, CSCs undergo aberrant differentiation and do not respond to homeostatic controls as they undergo self-renewal (25).”
BackgroundPurification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
Bhatia, M., Wang, J. C. Y., Kapp, U., Bonnet, D., & Dick, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5320 · Cited by 850 · cited 1×
“Two landmark studies involving immune-deficient mice models showed that leukemic cells expressing the same markers seen in adult human hematopoietic stem cells (CD34+CD38−) initiated hematopoietic malignancy (15, 38).”
BackgroundClonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia
Jan, M., Snyder, T. M., Corces-Zimmerman, M. R., Vyas, P., Weissman, I. L., Quake, S. R., & Majeti, R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004315 · Cited by 721 · cited 1×
“Another theory suggests that leukemia stem cells arise from clonal evolution (41).”
BackgroundDemoulin, J., Bertholet, M., Chevigne, M., Legrand, V., Rénier, J., Soumagne, D., Soyeur, D., Limet, R., & Kulbertus, H. (1981) · British heart journal · doi:10.1136/hrt.46.3.320 · Cited by 595 · cited 1×
“Similarities between somatic cells and CSCs suggest an association between reprogramming in CSCs and progression of disease (111).”
BackgroundTumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Rockwell, S., Dobrucki, I., Kim, E., Marrison, S., & Vu, V. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167087 · Cited by 511
Evaluating intrinsic and non-intrinsic cancer risk factors
Wu, S., Zhu, W., Thompson, P., & Hannun, Y. A. (2018) · Nature Communications · doi:10.1038/s41467-018-05467-z · Cited by 437
Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance
Chang, J. C. (2016) · Medicine · doi:10.1097/md.0000000000004766 · Cited by 435
Nagao, A., Kobayashi, M., Koyasu, S., Chow, C. C. T., & Harada, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020238 · Cited by 402
Sell, S., & Pierce, G. B. (1994) · PubMed · Cited by 380
Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
Brassart-Pasco, S., Brézillon, S., Brassart, B., Ramont, L., Oudart, J.-B., & Monboisse, J. C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00397 · Cited by 335
Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
Schulz, A., Meyer, F., Dubrovska, A., & Borgmann, K. (2019) · Cancers · doi:10.3390/cancers11060862 · Cited by 303
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Tam, S. Y., Wu, V. W. C., & Law, H. K. W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00486 · Cited by 298
FOLBERG, R., & MANIOTIS, A. J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0810.x · Cited by 275 · cited 1×
“reported highly invasive and metastatic human melanoma cells with tumor growth independent of angiogenesis, suggesting the generation of vascular channels by cancer cells without the involvement of endothelial cells (118).”
BackgroundVEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D. J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. (2015) · Oncogene · doi:10.1038/onc.2014.257 · Cited by 267 · cited 17×
“With regards to human cancer cell lines, that is brain, uterine cervix, lung, colon, bladder, and synovium derived cell lines, double-network hydrogel has been utilized to create spheroids with elevated levels of stemness-related genes SOX2, OCT3/4, and NANOG in vitro within 24h of seeding (139).”
BackgroundInfluentialAngiogenesis as a hallmark of solid tumors - clinical perspectives
Majidpoor, J., & Mortezaee, K. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00602-3 · Cited by 267 · cited 1×
“The formation of new blood vessels, known as angiogenesis, is a crucial process in solid tumor development (4).”
BackgroundOn the Stem Cell Origin of Cancer
Sell, S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091064 · Cited by 257 · cited 1×
“The stem cell theory of cancer (Figure 1A) includes two major concepts: 1) cancer arises from stem cells that are present in the tissues of both children and adults; and 2) cancer cells originate from the cells of normal tissues, including stem cells, proliferating cells, and terminally differentiated cells (20).”
BackgroundPrigione, A., Rohwer, N., Hoffmann, S., Mlody, B., Drews, K., Bukowiecki, R., Blümlein, K., Wanker, E. E., Ralser, M., Cramer, T., et al. (2014) · Stem Cells · doi:10.1002/stem.1552 · Cited by 254
HIF-1 in cancer therapy: two decade long story of a transcription factor
Soni, S., & Padwad, Y. S. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1301680 · Cited by 251
Peng, S., Maihle, N. J., & Huang, Y. (2010) · Oncogene · doi:10.1038/onc.2009.500 · Cited by 250
Stemness-related markers in cancer
Zhang, X., Zhao, W., & Li, Y. (2017) · Cancer Translational Medicine · doi:10.4103/ctm.ctm_69_16 · Cited by 245 · cited 2×
“Several markers have been reported to be expressed in CSCs including the Yamanaka transcription factors OCT4, NANOG, SOX2, KLF4, and c-MYC (62, 63).”
BackgroundSelf-citationZhang, P., Yao, Q., Lu, L., Li, Y., Chen, P.-J., & Duan, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.011 · Cited by 231 · cited 1×
“promoters to upregulate expression (53).”
Self-citationEmerging role of KLF4 in human gastrointestinal cancer
Wei, D., Kanai, M., Huang, S., & Xie, K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi243 · Cited by 224
Zhu, P., He, F., Hou, Y., Tu, G., Li, Q., Jin, T., Zeng, H., Qin, Y., Wan, X., Qiao, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-020-01638-9 · Cited by 216 · cited 1×
“identified a hypoxia-induced long non-coding RNA (lncRNAs) that contributes to the development of BCSC by creating a complex with insulin-like growth factor 2 mRNAbinding protein 1 (IGF2BP1) that stabilizes c-MYC mRNA (106).”
BackgroundFunctional characterization of SOX2 as an anticancer target
Zhang, S., Xiong, X., & Sun, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00242-3 · Cited by 206
He, Z., & Zhang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741305 · Cited by 203
Inherent DNA‐binding specificities of the HIF‐1α and HIF‐2α transcription factors in chromatin
Smythies, J. A., Sun, M., Masson, N., Salama, R., Simpson, P. D., Murray, E., Neumann, V., Cockman, M. E., Choudhry, H., Ratcliffe, P. J., et al. (2019) · The EMBO Reports · doi:10.15252/embr.201846401 · Cited by 195
Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
Afify, S. M., & Seno, M. (2019) · Cancers · doi:10.3390/cancers11030345 · Cited by 182
Zhang, X., Powell, K. A., & Li, L. (2020) · Cancers · doi:10.3390/cancers12123765 · Cited by 176
Cancer Stem Cell Plasticity – A Deadly Deal
Thankamony, A. P., Saxena, K., Murali, R., Jolly, M. K., & Nair, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00079 · Cited by 171 · cited 1×
“The validity of all three models in explaining the origin of CSCs attributes to the cellular plasticity seen with different cancer types (37).”
BackgroundYin, X., Zhang, B.-H., Zheng, S.-S., Gao, D.-M., Qiu, S.-J., Wu, W.-Z., & Ren, Z.-G. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0119-3 · Cited by 164
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
Lu, X., Mazur, S. J., Lin, T., Appella, E., & Xu, Y. (2014) · Oncogene · doi:10.1038/onc.2013.209 · Cited by 163 · cited 1×
“Abnormal expression of NANOG, a differentiated HOX domain protein, has been reported in several human cancers including breast cancer (76), lung cancer (77), adenocarcinoma (78), and gastric cancer (79).”
BackgroundKnockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells
Lu, Y., Zhu, H., Shan, H., Lu, J., Chang, X., Li, X., Lu, J., Fan, X., Zhu, S., Wang, Y., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.009 · Cited by 160 · cited 1×
“For example, in a pancreatic cancer tissue microarray analysis of 43 cases, high expression of NANOG predicted worse prognosis, and knockdown of both NANOG and OCT4 inhibited stemness of pancreatic cancer cells (81).”
BackgroundYan, Y., Liu, F., Han, L., Zhao, L., Chen, J., Olopade, O. I., He, M., & Wei, M. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0925-x · Cited by 160
Poli, V., Fagnocchi, L., Fasciani, A., Cherubini, A., Mazzoleni, S., Ferrillo, S., Miluzio, A., Gaudioso, G., Vaira, V., Turdo, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03264-2 · Cited by 157 · cited 1×
“This de-differentiation creates a more progenitor-like state that allows for acquisition of stem cell traits by c-MYC activation of de novo oncogenic enhancers, supporting CSC development (104).”
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
Jin, X., Dai, L., Ma, Y., Wang, J., & Liu, Z. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01370-0 · Cited by 150
Liu, Y., Yang, M., Luo, J., & Zhou, H. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-00087-0 · Cited by 149 · cited 2×
“On the other hand, CSCs are considered to be the “seeds” of cancer and are believed to be “awakened” with radiation, leading to recurrence and metastasis post-radiation (88).”
BackgroundLai, X., Li, Q., Wu, F., Lin, J., Chen, J., Zheng, H., & Guo, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00760 · Cited by 143
Zhang, D., Sun, B., Zhao, X., Ma, Y., Ji, R., Gu, Q., Dong, X., Li, J., Liu, F., Jia, X., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-207 · Cited by 138 · cited 1×
“Another study found that a hypoxic tumor microenvironment increased the population of CSCs, thereby accelerating VM channel formation in triple negative breast cancer (121).”
BackgroundIbrahim, E. E., Babaei-Jadidi, R., Saadeddin, A., Spencer-Dene, B., Hossaini, S., Abuzinadah, M., Li, N., Fadhil, W., Ilyas, M., Bonnet, D., et al. (2012) · Stem Cells · doi:10.1002/stem.1182 · Cited by 135
Characterization of a hierarchy in human acute myeloid leukemia progenitor cells
Sutherland, H., Blair, A., & Zapf, R. (1996) · Blood · doi:10.1182/blood.v87.11.4754.bloodjournal87114754 · Cited by 135 · cited 1×
“Within the same decade, tumor transplantation studies supported the theory that cancer was maintained by a small population of stem-like cells (22, 23).”
BackgroundCytokine and Chemokine Signals of T‐Cell Exclusion in Tumors
Zhang, Y., Guan, X.-Y., & Jiang, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594609 · Cited by 133 · cited 1×
“This infiltration can be influenced by the chemotactic signals and interactions between cancer cells, stromal cells, and immune cells (3).”
BackgroundHypoxia-inducible factors in cancer stem cells and inflammation
Peng, G., & Liu, Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.003 · Cited by 123 · cited 1×
“All three heterodimerize with the HIF-1b subunit and are subject to posttranslational regulation that is dependent on oxygen levels in the environment (52).”
BackgroundRole of hypoxia inducible factor-1 in cancer stem cells (Review)
Zhang, Q., Han, Z., Zhu, Y., Chen, J., & Li, W. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11655 · Cited by 123 · cited 1×
“A core mechanism of stemness generation and maintenance induced by hypoxia are hypoxia inducible factors (HIFs) (Figure 2) (49, 50).”
BackgroundDifferences and similarities between cancer and somatic stem cells: therapeutic implications
Rossi, F., Noren, H., Jove, R., Beljanski, V., & Grinnemo, K.-H. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02018-6 · Cited by 121
KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth
Riverso, M., Montagnani, V, & Stecca, B. (2017) · Oncogene · doi:10.1038/onc.2016.481 · Cited by 115 · cited 1×
“For example, in colon cancer KLF4 is a potent tumor suppressor, while in melanoma KLF4 expression promotes cell proliferation (97, 98).”
BackgroundSox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells
Xu, Y., Dong, X., Qi, P., Ye, Y., Shen, W., Leng, L., Wang, L., Li, X., Luo, X., Chen, Y., et al. (2017) · Stem Cells · doi:10.1002/stem.2720 · Cited by 113 · cited 3×
“Recently, Zhu et al. identified a hypoxia-induced long non-coding RNA (lncRNAs) that contributes to the development of BCSC by creating a complex with insulin-like growth factor 2 mRNAbinding protein 1 (IGF2BP1) that stabilizes c-MYC mRNA (106).”
BackgroundOverview of the roles of Sox2 in stem cell and development
Feng, R., & Wen, J. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0317 · Cited by 110
Hasmim, M., Noman, M. Z., Messai, Y., Bordereaux, D., Gros, G., Baud, V., & Chouaib, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302140 · Cited by 109
Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment
Mun, J.-Y., Leem, S.-H., Lee, J. H., & Kim, H. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864739 · Cited by 103 · cited 1×
“matrix proteins, and secrete growth factors that can promote tumor growth (2).”
BackgroundTherapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
Sun, H.-R., Wang, S., Yan, S.-C., Zhang, Y., Nelson, P. J., Jia, H.-L., Qin, L.-X., & Dong, Q.-Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01104 · Cited by 103
Hepburn, A. C., Steele, R. E., Veeratterapillay, R., Wilson, L., Kounatidou, E. E., Barnard, A., Berry, P., Cassidy, J., Moad, M., El‐Sherif, A., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0712-y · Cited by 98 · cited 1×
“Multiple studies have implicated that CSCs share critical properties with embryonic cells through the elevated expression of Yamanaka factors, which supports the impact of these pluripotency factors in tumorigenesis (18, 19).”
BackgroundThe role of pluripotency factors to drive stemness in gastrointestinal cancer
Müller, M., Hermann, P. C., Liebau, S., Weidgang, C. E., Seufferlein, T. T. W., Kleger, A., & Perkhofer, L. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.02.005 · Cited by 97
Kawanami, D., Mahabeleshwar, G. H., Lin, Z., Atkins, G. B., Hamik, A., Haldar, S. M., Maemura, K., LaManna, J. C., & Jain, M. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025346 · Cited by 95
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Gong, L., Yan, Q., Zhang, Y., Fang, X., Liu, B., & Guan, X. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0393-5 · Cited by 91
Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels
Suzuka, J., Tsuda, M., Wang, L., Kohsaka, S., Kishida, K., Semba, S., Sugino, H., Aburatani, S., Frauenlob, M., Kurokawa, T., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00692-2 · Cited by 91
Molecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X.-X., Qian, D. Z., & Dai, M.-S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 89 · cited 1×
“Therefore, in cancer, when c-MYC levels are high, HIF and cMYC collectively remodel cellular processes to increase oncogenic potential including angiogenesis and metastasis (105).”
BackgroundSelf-citationOverexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma
Lin, T., Ding, Y.-Q., & Li, J. (2012) · Medical Oncology · doi:10.1007/s12032-011-9860-9 · Cited by 88 · cited 1×
“Abnormal expression of NANOG, a differentiated HOX domain protein, has been reported in several human cancers including breast cancer (76), lung cancer (77), adenocarcinoma (78), and gastric cancer (79).”
BackgroundPost-translational modification of OCT4 in breast cancer tumorigenesis
Cho, Y., Kang, H. G., Kim, S.-J., Lee, S., Jee, S., Ahn, S. G., Kang, M. J., Song, J. S., Chung, J.-Y., Yi, E. C., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0079-6 · Cited by 84
Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation.
Bae, K., Dai, Y., Vieweg, J., & Siemann, D. W. (2016) · PubMed · Cited by 79
Vaupel, P. W., Flood, A. B., & Swartz, H. M. (2021) · Applied Magnetic Resonance · doi:10.1007/s00723-021-01383-6 · Cited by 79
Sun, H., Yao, N., Siqi, C., Linqi, L., Shiqi, L., Zhao, Y., Guanjie, S., Danfang, Z., & Zhi, Y. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0209 · Cited by 78
López-Codony, V., & Tavassoli, M. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101017 · Cited by 77
Gao, H., Teng, C.-Y., Huang, W., Peng, J.-J., & Wang, C.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921643 · Cited by 76
Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Glioblastoma
Iranmanesh, Y., Jiang, B., Favour, O. C., Dou, Z., Wu, J., Li, J., & Sun, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.582694 · Cited by 74
Wang, P., Zhao, L., Gong, S., Xiong, S., Wang, J., Zou, D., Pan, J., Deng, Y., Yan, Q., Wu, N., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03598-8 · Cited by 70
Wang, Y., Yang, C.-H., Gu, Q.-Q., Sims, M., Gu, W., Pfeffer, L., & Yue, J.-M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130341 · Cited by 68 · cited 1×
“physiological processes including cell differentiation, inflammation, apoptosis, inflammation, and angiogenesis (96).”
BackgroundReprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
Linde, M. H., Fan, A. C., Köhnke, T., Trotman-Grant, A. C., Gurev, S. F., Phan, P., Zhao, F., Haddock, N. L., Nuno, K. A., Gars, E. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0502 · Cited by 68
Reprogramming of human cancer cells to pluripotency for models of cancer progression
Kim, J., & Zaret, K. S. (2015) · The EMBO Journal · doi:10.15252/embj.201490736 · Cited by 67 · cited 2×
“Frontiers in Oncology 02 types, which can contribute to tumor heterogeneity and tumor progression (7).”
BackgroundSOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
Liu, P., Tang, H., Song, C.-L., Wang, J., Chen, B., Huang, X.-J., Pei, X., & Liu, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00942 · Cited by 66 · cited 1×
“Furthermore, elevated levels of SOX2 expression have also been associated with several cancers including breast (68), prostate (69), and pancreatic cancer (70).”
BackgroundHasmim, M., Noman, M. Z., Lauriol, J., Benlalam, H., Mallavialle, A., Rosselli, F., Mami-Chouaib, F., Alcaide-Loridan, C., & Chouaib, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101011 · Cited by 65 · cited 1×
“Numerous studies have also identified dynamic roles of NANOG in the hypoxic tumor microenvironment including but not limited to the activation of tumor autophagy in non–small lung carcinoma cells (82), colony formation in colorectal CSCs (83), and resistance to mediated lysis in non-small lung cell carcinoma cells (84…”
BackgroundSlug is a key mediator of hypoxia induced cadherin switch in HNSCC: Correlations with poor prognosis
Zhang, J., Cheng, Q., Zhou, Y., Wang, Y., & Chen, X. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.08.003 · Cited by 64
Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms
Ratajczak, M., Bujko, K., Mack, A. A., Kucia, M., & Ratajczak, J. (2018) · Leukemia · doi:10.1038/s41375-018-0294-7 · Cited by 59 · cited 1×
“Transformation is likely to arise from environmental inputs such as tissue regeneration (30), infections (31), toxins (32), as well as intrinsic and non-intrinsic factors that lead to DNAmutations (33).”
BackgroundLu, H., Lyu, Y., Tran, T. M. L., Lan, J., Xie, Y., Yang, Y., Murugan, N. L., Wang, Y. J., & Semenza, G. L. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109757 · Cited by 58 · cited 1×
“NANOG then serves as a HIF-1 coactivator for the transcription of telomerase reverse transcriptase, an essential component for telomerase activity in telomere elongation (85, 86).”
BackgroundCancer immunotherapy: a promising dawn in cancer research.
Bondhopadhyay, B., Sisodiya, S., Chikara, A., Khan, A., Tanwar, P., Afroze, D., Singh, N., Agrawal, U., Mehrotra, R., & Hussain, S. (2020) · Europe PMC (PubMed Central) · Cited by 57
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
Zimmermannova, O., Caiado, I., Ferreira, A. G., & Pereira, C.-F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714822 · Cited by 56
Asymmetric Cell Division and Tumor Heterogeneity
Li, Z., Zhang, Y. Y., Zhang, H., Yang, J., Chen, Y., & Lu, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.938685 · Cited by 56 · cited 1×
“Thus, CSCs divide asymmetrically to maintain a subpopulation CSCs while also generating transient cells that undergo symmetric divisions with highly proliferative capabilities (34).”
BackgroundHypoxia in cervical cancer: from biology to imaging
Lyng, H., & Malinen, E. (2017) · Clinical and Translational Imaging · doi:10.1007/s40336-017-0238-7 · Cited by 55
VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors
Röhrig, F., Vorlová, S., Hoffmann, H., Wartenberg, M., Escorcia, F. E., Keller, S., Tenspolde, M., Weigand, I., Gätzner, S., Manova, K., et al. (2017) · Oncogene · doi:10.1038/onc.2016.182 · Cited by 54
Normal and cancer stem cells of the human female reproductive system
López, J., Valdez-Morales, F. J., Benítez-Bribiesca, L., Cerbón, M. A., & Carrancá, A. G. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-53 · Cited by 52 · cited 2×
“Frontiers in Oncology 03 term self-renewal; 2) their progeny differentiates to functional, specialized cells; and 3) they faithfully respond to homeostatic controls within their environment (24).”
BackgroundWang, P., Gong, S., Liao, B., Pan, J., Wang, J., Zou, D., Zhao, L., Xiong, S., Deng, Y., Yan, Q., et al. (2021) · Journal of Cancer · doi:10.7150/jca.54402 · Cited by 51
bHLH–PAS Proteins: Their Structure and Intrinsic Disorder
Kolonko, M., & Greb‐Markiewicz, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153653 · Cited by 49
Liu, Q., Palmgren, V. A. C., Danen, E. H. J., & Dévédec, S. E. L. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07802-6 · Cited by 48
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
Gaggianesi, M., Franco, S. D., Pantina, V. D., Porcelli, G., D’Accardo, C., Verona, F., Veschi, V., Colarossi, L., Faldetta, N., Pistone, G., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.702642 · Cited by 47
Shan, F., Huang, Z., Xiong, R., Huang, Q., & Li, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28953 · Cited by 47
Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer.
Hatefi, N., Nouraee, N., Parvin, M., Ziaee, S. A. M., & Mowla, S. J. (2012) · PubMed Central · Cited by 46
Cell Reversal From a Differentiated to a Stem-Like State at Cancer Initiation
Carvalho, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00541 · Cited by 46
Hypoxia in Cell Reprogramming and the Epigenetic Regulations
Nakamura, N., Shi, X., Darabi, R., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.609984 · Cited by 43 · cited 1×
“As previously discussed, hypoxia and Yamanaka factors have been found to be related in the sense that hypoxia can induce the expression of Yamanaka factors, which may contribute to the reprogramming and maintenance of cells into a pluripotent state (64) (Figure 3).”
BackgroundSelf-citationLópez-Anguita, N., Gassaloglu, S. I., Stötzel, M., Typou, M., Virta, I., Hetzel, S., Buschow, R., Koksal, B., Atilla, D., Maitschke-Rajasekharan, R., et al. (2022) · Development · doi:10.1242/dev.200679 · Cited by 41 · cited 1×
“Studies have shown that hypoxia can induce the expression of Yamanaka factors in cells, which can lead to the reprogramming of cells into a pluripotent state (11, 12).”
BackgroundWang, Y., Bibi, M., Min, P., Deng, W., Zhang, Y., & Du, J. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0180-y · Cited by 41
Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter
Hasmim, M., Janji, B., Khaled, M., Noman, M. Z., Louache, F., Bordereaux, D., Abderamane, A., Baud, V., Mami‐Chouaib, F., & Chouaïb, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600981 · Cited by 40
Potential application of cell reprogramming techniques for cancer research
Saito, S., Lin, Y., Nakamura, Y., Eckner, R., Wuputra, K., Kuo, K., Lin, C., & Yokoyama, K. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2924-7 · Cited by 40 · cited 6×
“Specifically in certain cancer cells, KLF4 has been demonstrated to promote hypoxia-induced apoptosis by upregulating the expression of pro-apoptotic genes, and to inhibit hypoxia-induced angiogenesis by downregulating the expression of pro-angiogenic factors such as VEGF (vascular endothelial growth factor) (103).”
BackgroundInfluentialEvaluating the Expression of Oct4 as a Prognostic Tumor Marker in Bladder Cancer
Hatefi, N., Nouraee, N., Parvin, M., Ziaee, S., & Mowla, S. (2012) · Iranian Journal of Basic Medical Sciences · doi:10.22038/ijbms.2012.4934 · Cited by 40 · cited 1×
“Elevated expression levels have been found in several cancers including lung, breast (89), bladder (90), liver (91), and pancreatic cancer (79).”
BackgroundMelanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Bernhardt, M., Novak, D., Assenov, Y., Orouji, E., Knappe, N., Weina, K., Reith, M., Larribere, L., Gebhardt, C., Plass, C., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.007 · Cited by 37 · cited 1×
“For example, epigenetic modifications in melanoma cells were induced by reprogramming them into induced pluripotent cancer cells that were able to differentiate into nontumorigenic lineages (65).”
BackgroundMicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer
Niu, T., Zhang, W., & Xiao, W. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01716-8 · Cited by 36 · cited 3×
“Recently, Zhu et al. identified a hypoxia-induced long non-coding RNA (lncRNAs) that contributes to the development of BCSC by creating a complex with insulin-like growth factor 2 mRNAbinding protein 1 (IGF2BP1) that stabilizes c-MYC mRNA (106).”
BackgroundWang, R.-A., Li, Z.-S., Zhang, H.-Z., Zheng, P.-J., Li, Q.-L., Shi, J., Yan, Q.-G., Ye, J., Wang, J.-B., Guo, Y., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12078 · Cited by 34
Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments
Bharti, S. K., Kakkad, S. M., Danhier, P., Wildes, F. B., Penet, M., Krishnamachary, B., & Bhujwalla, Z. M. (2019) · Neoplasia · doi:10.1016/j.neo.2018.12.004 · Cited by 34
Effects of infections on the pathogenesis of cancer
Liardo, R. L. E., Borzì, A. M., Spatola, C., Martino, B., Privitera, G., Basile, F., Biondi, A., & Vacante, M. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_339_19 · Cited by 31
Wegge, M., Dok, R., & Nuyts, S. (2021) · Cancers · doi:10.3390/cancers13235959 · Cited by 31
Lin, P., Wang, W. T., Sun, B., et al. (2012) · PubMed · Cited by 30
Recent Research on Methods to Improve Tumor Hypoxia Environment
Zhu, X., Du, J., Zhu, D. Y., Ren, S., Chen, K., & Zhu, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5721258 · Cited by 30
Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting)
Ghasemi, S., Xu, S., Nabavi, S. M., Amirkhani, M. A., Sureda, A., Tejada, S., & Lorigooini, Z. (2021) · Phytotherapy Research · doi:10.1002/ptr.7059 · Cited by 30
Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer
Fatma, H., & Siddique, H. R. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1915137 · Cited by 29
Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)
Issah, M. A., Wu, D., Zhang, F., Zheng, W., Liu, Y., Fu, H., Zhou, H., Chen, R., & Shen, J. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5287 · Cited by 29
Lin, P.-F., Wang, W., Sun, B.-C., Cai, W.-J., Li, L., Lu, H.-H., Han, C.-R., & Zhang, J.-M. (2012) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2012.19.016 · Cited by 28
Hansen, Q., Bachas, C., Smit, L., & Cloos, J. J. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.140 · Cited by 25 · cited 1×
“Frontiers in Oncology 04 lymphoblastic leukemia (39).”
Current status in cancer cell reprogramming and its clinical implications
İzgi, K., Canatan, H., & İskender, B. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2258-5 · Cited by 24
Environmental Exposures and Cancer: Using the Precautionary Principle
Cohen, L., & Jefferies, A. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.ed91 · Cited by 24
A systematic study of HIF1A cofactors in hypoxic cancer cells
Zhang, Y., Wang, S., Hu, H., & Li, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-23060-9 · Cited by 20 · cited 1×
“KLF4 has been shown to inhibit the expression of HIF-1a, the regulatory subunit of HIF-1, under normoxic conditions (21% O2), thereby reducing the cellular response to hypoxia (101).”
BackgroundOCT4 directly regulates stemness and extracellular matrix-related genes in human germ cell tumours
Song, B., Kim, D.-K., Shin, J., Bae, S.-H., Kim, H. Y., Won, B., Kim, J.-K., Youn, H., Kim, S., Kang, S. W., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.145 · Cited by 20 · cited 1×
“Specifically, in germ-line tumors, knockdown of OCT4 was demonstrated to directly reduce cell proliferation and stemness (92).”
BackgroundReprogramming of Cancer Cells into Induced Pluripotent Stem Cells Questioned
Bang, J. S., Choi, N. Y., Lee, M., Ko, K., Park, Y. S., & Ko, K. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc19067 · Cited by 20
Alternative models of cancer stem cells: The stemness phenotype model, 10 years later
Kaushik, V., Kulkarni, Y., Felix, K., Azad, N., Iyer, A. K. V., & Yakisich, J. S. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.934 · Cited by 19
Liu, H., Tang, H.-T., Yang, H.-D., Deng, T., Xu, Y.-P., Xu, S.-Q., Peng, L., Wang, Z., Fang, Q., Kuang, X.-Y., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.563316 · Cited by 19 · cited 1×
“Both OCT4A and OCT4B have also been shown to have pro-angiogenic characteristics, facilitating the transition of CSC to tumor endothelial-like cells in liver cancer (95).”
BackgroundLu, C.-S., Hsieh, J., Lin, C. Y., Tsai, H.-W., Su, B.-H., Shieh, G., Su, Y.-C., Lee, C.-H., Chang, M.-Y., Wu, C.-L., et al. (2015) · Gene Therapy · doi:10.1038/gt.2014.122 · Cited by 18
HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy
Kwak, J., Lee, N.-H., Lee, H.-Y., Hong, I., & Nam, J.-S. (2016) · OncoTarget · doi:10.18632/oncotarget.9846 · Cited by 17
Wang, T., Guo, Y., Liu, S., Zhang, C., Cui, T., Ding, K., Wang, P., Wang, X., & Wang, Z. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.628192 · Cited by 17
Zhao, L., Liu, Z., Yang, F., Zhang, Y., Xue, Y., Miao, H., Liao, X., Huang, H., & Li, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-47891-1 · Cited by 16
Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
Venizelos, A., Engebrethsen, C., Deng, W., Geisler, J., Geisler, S., Iversen, G., Aas, T., Aase, H., Seyedzadeh, M., Steinskog, E. S., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01090-2 · Cited by 16
Getting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells
Colvin, H., & Mori, M. (2017) · Proceedings of the Japan Academy. Series B, Physical and biological sciences · doi:10.2183/pjab.93.009 · Cited by 13
OCT4B mediates hypoxia-induced cancer dissemination
Lin, S.-C., Chung, C.-H., Chung, C.-H., Kuo, M.-H., Hsieh, C.-H., Chiu, Y.-F., Shieh, Y., Chou, Y.-T., & Wu, C.-W. (2018) · Oncogene · doi:10.1038/s41388-018-0487-6 · Cited by 12
Xiong, S., Wang, D., Tang, Y., Lu, S., Huang, L., Wu, Z., Lei, S., Liang, G., Yang, D., Li, D., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147288 · Cited by 11
Self-citationWang, J., & Wang, C. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.7.2 · Cited by 11
Vaupel, P., Flood, A., & Swartz, H. (2021) · Applied Magnetic Resonance · doi:10.1007/s00723-021-01414-2 · Cited by 10
Induction of Nanog in neural progenitor cells for adaptive regeneration of ischemic brain
Jung, G.-A., Kim, J., Park, H., Lee, H., Chang, M., Cho, K., Song, B., Kim, H., Kwon, Y. K., & Oh, I. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00880-3 · Cited by 9 · cited 1×
“Although the exact molecular mechanisms of NANOG remains poorly understood, NANOG expression has been associated with both the development and maintenance of pluripotent state of CSCs (80).”
BackgroundThe Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis
Cheng, W.-Y., Wang, H., Yuan, J.-J., Cheng, Z., Xing, D., & Zhang, M.-G. (2018) · BioMed Research International · doi:10.1155/2018/3429261 · Cited by 8
Stemness of Human Pluripotent Cells: Hypoxia-Like Response Induced by Low Nitric Oxide
Caballano‐Infantes, E., Díaz, I., Hitos, A. B., Cahuana, G. M., Martínez-Ruiz, A., Soria-Juan, B., Rodríguez-Griñolo, R., Hmadcha, A., Martín, F., Soria, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10091408 · Cited by 6
Miyagi-Shiohira, C., Saitoh, I., Watanabe, M., & Noguchi, H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030454 · Cited by 3
Reynaud, E. (2022) · Philosophical Transactions of the Royal Society A · doi:10.1098/rsta.2020.0389 · Cited by 2 · cited 1×
“These low oxygen levels have been noted in prostate (44), cervix (45), breast (46), head and neck cancers (47), with levels depending on the size, stage, initial oxygenation level, and the method applied to measure the oxygen within the solid tumor (48).”
Method
Cited by
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J.-M., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 188
“110 This dynamic equilibrium between CSCs and non-CSCs makes it dif fi cult to eradicate CSCs by targeting speci fi c markers, as non-CSCs can also repopulate tumors.”
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer
Ronca, R., & Supuran, C. T. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189120 · Cited by 129
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
Verona, F., Bella, S. D., Schirano, R., Manfredi, C., Angeloro, F., Bozzari, G., Todaro, M., Giannini, G., Stassi, G., & Veschi, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529847 · Cited by 56
Kunachowicz, D., Tomecka, P., Sędzik, M., Kalinin, J., Kuźnicki, J., & Rembiałkowska, N. (2025) · Cells · doi:10.3390/cells14141057 · Cited by 54
“HIF-1 α is a powerful glycolysis-inducing factor through binding to hypoxia-responsive elements, which are present in the promoters of genes encoding key glycolytic enzymes and transporters, such as glucose transporters, hex-okinase 2, lactate dehydrogenase A, and monocarboxylate transporters [44].”
Metadata
- Authors
- Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y.
- Affiliations
- Western Michigan University (US)
- Corresponding author
- Li, Yong
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2023-08-08
- Volume
- 13
- Pages
- 1227884-1227884
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC10442830
- OpenAlex
- W4385658940
- Cited by
- 41
- References
- 150
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 10 · 2023: 1
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Western Michigan University
- Stryker
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- cancer stem cells, hypoxia, tumor reprogramming, dedifferentiation, Yamanaka factors, self-renewal, metastasis, tumor progression, normal stem cells, epigenetic modifications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.